Campion Asset Management Viatris Inc Transaction History

Campion Asset Management

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$11.27 - $13.53 $41,338 - $49,628	-3,668 Reduced 26.0%	10,438 $124,000
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $3,508 - $4,340	-400 Reduced 2.76%	14,106 $152,000
Q1 2023 May 12, 2023	BUY	$9.2 - $12.26 $5,106 - $6,804	555 Added 3.98%	14,506 $139,000
Q4 2022 Mar 22, 2023	SELL	$8.72 - $11.56 $27,119 - $35,951	-3,110 Reduced 18.23%	13,951 $155,000
Q2 2022 Jul 21, 2022	BUY	$9.95 - $12.27 $52,963 - $65,313	5,323 Added 45.35%	17,061 $179,000
Q1 2022 May 10, 2022	BUY	$9.81 - $15.4 $1,962 - $3,080	200 Added 1.73%	11,738 $128,000
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $69,928 - $84,909	-5,784 Reduced 33.39%	11,538 $156,000
Q3 2021 Nov 16, 2021	BUY	$13.25 - $15.13 $28,805 - $32,892	2,174 Added 14.35%	17,322 $235,000
Q2 2021 Jul 23, 2021	BUY	$12.97 - $16.15 $34,526 - $42,991	2,662 Added 21.32%	15,148 $216,000
Q1 2021 Apr 27, 2021	BUY	$13.59 - $18.54 $169,684 - $231,490	12,486 New	12,486 $174,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Campion Asset Management, based on Form 13F filings with the SEC.

Stay updated on Campion Asset Management with notifications on news.